Neuroelectrics

Neuroelectrics is a Barcelona-based neurotechnology company specializing in the development of wireless, high-density systems for electroencephalography and transcranial electrical stimulation. The company's flagship Starstim platform integrates multi-channel transcranial current stimulation with simultaneous EEG recording in a single, wearable headset, enabling researchers and clinicians to both monitor and modulate brain activity in real time. This combined approach distinguishes Neuroelectrics from single-modality devices, offering a more comprehensive tool for closed-loop neuromodulation applications. The platform is designed to support high-density electrode configurations, allowing for precise spatial targeting of cortical regions across a range of experimental and therapeutic protocols.

Neuroelectrics has secured Series B funding of approximately 15 million dollars, reflecting growing investor confidence in the commercial and clinical potential of its technology. The company has built a substantial presence in the academic research community, with its systems deployed across leading neuroscience institutions and university hospitals worldwide. Neuroelectrics has pursued clinical development in areas including epilepsy, depression, and stroke rehabilitation, advancing feasibility and efficacy studies that position the platform as a credible candidate for regulated therapeutic use. These milestones have helped the company move progressively from a research tools provider toward a broader clinical neuromodulation company.

Neuroelectrics occupies a strategically important position in the neurotech landscape by addressing one of the field's central challenges, which is the ability to both measure and modify brain activity with a single integrated device. As the industry moves toward personalized, data-driven neuromodulation, the capacity to record high-quality neural signals alongside stimulation delivery becomes critical for optimizing treatment protocols and improving patient outcomes. The company's open and flexible platform also supports the kind of iterative, collaborative research needed to establish the evidence base that will ultimately drive clinical adoption. In this respect, Neuroelectrics serves not only as a toolmaker but as an enabler of the broader scientific progress the neuromodulation field requires to mature.